Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Our Top Trade Ideas Delivered Daily - 65% Off Now
get this deal
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
McNicoll
McNicoll, Lewis & Vlak Downgrades Genomic Health to Holld
McNicoll, Lewis & Vlak Reaffirms Transcept Pharmaceuticals Buy, $21 PT
McNicoll, Lewis & Vlak Maintains Keryx Biopharmaceuticals Buy, $18 PT
McNicoll, Lewis & Vlak Reaffirms Transcept Pharmaceuticals Buy, $21 PT
McNicoll, Lewis & Vlak Maintains Keryx Biopharmaceuticals Buy, $18 PT
McNicoll, Lewis & Vlak Maintains Royal Gold Buy, $97.70 PT
McNicoll, Lewis & Vlak Reiterates Affymax Buy, $12 PT
McNicoll, Lewis & Vlak Maintains Royal Gold Buy, $97.70 PT
McNicoll, Lewis & Vlak Reiterates Affymax Buy, $12 PT
McNicoll, Lewis & Vlak Reiterates Ligand Pharmaceuticals Buy, $30 Price Target
McNicoll, Lewis & Vlak Maintains Spectrum Pharmaceuticals Buy, $20.50 PT
Read More...
McNicoll Recent News
McNicoll, Lewis & Vlak Maintains Aastrom Biosciences Buy, $7.50 PT
McNicoll, Lewis & Vlak Reiterates Vivus Buy, $16 PT
McNicoll, Lewis & Vlak Maintains Peregrine Pharmaceuticals Buy, PT
McNicoll, Lewis & Vlak Maintains Keryx Biopharmaceuticals Buy, $18 PT
McNicoll, Lewis & Vlak Maintains Aeterna Zentaris Buy, PT
McNicoll, Lewis & Vlak Maintains Peregrine Pharmaceuticals Buy, PT
McNicoll, Lewis & Vlak Downgrades Transcept Pharmaceuticals, Lowers PT
McNicoll, Lewis & Vlak Reiterates Affymax Buy, $12 PT
McNicoll, Lewis & Vlak Maintains Icagen Hold
McNicoll, Lewis & Vlak Reiterates Corcept Therapeutics Buy, $8 PT
McNicoll, Lewis & Vlak Reiterates Inhibitex Buy, $7 PT
McNicoll, Lewis & Vlak Reiterates Rockwell Medical Buy, $16.50 PT
McNicoll, Lewis & Vlak Lowers SuperGen PT, Maintains Buy
McNicoll, Lewis & Vlak Reiterates Vivus Buy, $16 PT
McNicoll, Lewis & Vlak Maintains SuperGen Buy, $8 PT
McNicoll, Lewis & Vlak Reiterates Alnylam Pharmaceuticals Buy, $15 PT
Noravax's VLP Vaccine Closer To IND Filing
McNicoll, Lewis & Vlak LLC Maintains Buy Rating On XOMA Limited (XOMA)